InvenSense, Inc. (INVN)
Rosetta Genomics, Ltd. (ROSG)
Social Reality, Inc. (SCRI)
Torchlight Energy Resources, Inc. (TRCH)
InvenSense, Inc. (INVN)
InvenSense, Inc. (NYSE: INVN) is a leading provider of intelligent sensor system on chip (SoC) for motion and sound solutions in consumer electronic devices – including smartphones, tablets, wearables, gaming devices, optical image stabilization and remote controls for Smart TVs. The company’s patented InvenSense Fabrication Platform and patent-pending MotionFusion™ technology address the emerging needs of many mass-market consumer applications via improved performance, accuracy, and intuitive motion-, gesture- and sound-based interfaces.
Beginning with the world’s first dual-axis MEMS gyroscopes for the digital still camera market in 2006, InvenSense has developed a reputation for innovation within the industry by consistently delivering game changing solutions. In 2009, the company released the first integrated 3-axis motion processing solution for smartphones, and in 2010 it unveiled the world’s first single-chip integrated 6-axis MotionTracking™ device. Among the company’s latest solutions is the ICM-20728, which was recognized as the world’s first integrated 7-axis single-chip platform solution with onboard Digital Motion Processor (DMP™) upon its release in 2014. By remaining on the cutting-edge of the industry, InvenSense is in a formidable position to realize continued growth moving forward.
In March, the company continued to expand its industry presence through the announced availability of its InvenSense Positioning Library (IPL) software, which is designed to provide sensor assisted positioning in places where GPS accuracy isn’t adequate. This announcement further demonstrated the potentially massive reach of the company’s expansive product line.
“With more consumers using their smartphones for turn-by-turn navigation on foot or in vehicle, one of the most frustrating user experience issues is losing your GPS signal in an unfamiliar location or being re-routed erroneously due to multipath errors,” stated Ali Foughi, vice president of Marketing and Business Development at InvenSense. “With IPL technology, high accuracy location guidance is always available and provides Smartphone OEMs with a differentiated user experience and consumers with a more reliable navigation solution.”
Rosetta Genomics, Ltd. (ROSG)
Rosetta Genomics, Ltd. (NASDAQ: ROSG) leverages an integrative research platform to develop and commercialize a full range of microRNA-based molecular diagnostics and address critical needs in cancer and other disease areas. Building on its proprietary platform technologies and a strong IP portfolio, the company is working to solve unmet medical needs and improve the lives of patients through a proven combination of diagnostic expertise and therapeutic innovations.
The company’s current product pipeline includes an assortment of unique diagnostic tests for a collection of medical conditions – including thyroid neoplasia, heart failure, kidney rejection and Alzheimer’s disease. In recent months, Rosetta has worked to build on this pipeline and expand its presence in the industry, most notably through the acquisition of PersonalizeDx in April. PersonalizeDx is a rapidly growing molecular diagnostics and services company serving community-based pathologists, urologists, oncologists and other reference laboratories across the United States.
“The acquisition of PersonalizeDx will have wide-ranging, positive financial, commercial, operational and pipeline impact on Rosetta Genomics, and brings with it exceptional talent to complement the industry-leading team at Rosetta Genomics,” stated Kenneth A. Berlin, president and chief executive officer of Rosetta, in a recent news release. “In joining forces with PersonalizeDx, Rosetta Genomics will gain critically important commercial and revenue scale in the marketplace for oncology diagnostics.”
In May, Rosetta built on the momentum gained from its acquisition by releasing OncoGxOne™, the company’s next-generation sequencing panel that detects a vast number of genetic alterations implicated in cancer to provide clear, concise and actionable clinical recommendations from a single, comprehensive test. Moving forward, OncoGxOne™ will compete with currently available genomic profiling offerings through next-generation sequencing platforms that can identify potentially actionable cancer-driving mutations, which can be targeted by specific therapies.
Social Reality, Inc. (SCRI)
Social Reality, Inc. (OTCQB: SCRI) is connecting the social and digital spheres to offer brands, agencies and publishers new and measurable opportunities to target, reach and monetize their audiences. Through its proprietary technology platform, the company has unlocked a collection of new revenue streams for publishers by providing the tools needed to automate the digital advertising market.
The company’s collection of products includes three revolutionary services – SRAX, SR Innovation and Groupad – designed to improve performance for brands and publishers across all digital mediums. SRAX is an all-in-one platform that connects online publishers with advertisers and demand-side partners through real-time bidding (RTB) management in order to maximize the profitability of buying and selling ads. SR Innovation builds cutting-edge solutions designed to connect, engage and reward publishers’ core audiences. Groupad allows users to launch and manage social applications with one easy tool, providing a complete management solution for social and digital media campaigns.
Persistent dedication to quality and innovation has allowed SCRI to rapidly grow its presence within the advertising industry in recent years. During the first quarter of 2015, the company recorded a 626 percent year-over-year increase in revenue, marking the third consecutive quarter that the company had recorded quarter-over-quarter growth.
“Our revenue for the first quarter almost surpasses our entire 2014 yearly revenue and by the end of the second quarter we expect to almost double last year’s revenue,” stated Christopher Miglino, Chairman and Chief Executive Officer of SCRI. “We are experiencing significant growth this year, and Social Reality is well-positioned to participate in the explosive growth in digital ad spending.”
The continued industry shift towards RTB is expected to place SCRI in a strong position to continue experiencing rapid growth in the coming years. According to a report by eMarketer, RTB digital display ad spending in the United States accounted for $3.34 billion, or nearly one-fifth of total display spending, in 2013, and this figure is expected to grow to over $8.6 billion by 2017.
Torchlight Energy Resources, Inc. (TRCH)
Torchlight Energy Resources, Inc. (NASDAQ: TRCH) is an oil and gas Exploration and Production company with a primary focus on acquisition and development of highly profitable domestic oil fields. Based in Plano, Texas, the company currently holds interests in Texas, Kansas and Oklahoma, providing access to established plays including the Eagle Ford, Mississippian and Hunton. Torchlight’s focus on highly probable and profitable drilling and working interest programs that feature proven and bookable reserves has allowed the company to strategically position itself for tremendous growth moving forward.
Among Torchlight’s most promising projects is the Hunton Play, located in Logan and Kingfisher Counties, Oklahoma. The company’s interest in the area is divided into two unique projects: The Cimarron Project and The Chisholm Trail Project, of which Torchlight owns a 15 percent and 15.3 percent working interest, respectively. Combined, the two nearly contiguous projects cover an area of approximately 8,800 acres and fit well into the company’s strategic plan of leveraging new technologies to capitalize on established plays.
In September 2014, Torchlight acquired a 100 percent working interest in its 172,000 acre Orogrande Basin prospect. Through this agreement, the company received a five-year lease on the property that also carries additional five-year extension provisions. In March, Torchlight took a major step toward capitalizing on this interest by beginning drilling operations on its first well on the property. In May, the company built on this progress through the announcement that it had reached total depth on its initial test well.
In recent weeks, Torchlight has turned its attention toward investment in order to gain the flexibility required to maximize the value of its current projects. Earlier last week, the company announced that it had closed on the sale of nearly $10 million in Series A Convertible Preferred Stock. This move allowed the company to pay off its senior debt and prepare for continued growth into the future.